Healthcare Providers and Services
Company Overview of Musculoskeletal Transplant Foundation
Musculoskeletal Transplant Foundation, a non-profit tissue bank, provides grafts for transplantations. It offers bone and soft tissue grafts in the United States. Musculoskeletal Transplant Foundation was founded in 1987 and is based in Edison, New Jersey. The company has facilities in Pennsylvania, California, Minnesota, and Germany, as well as recovery sites in Wisconsin, California, Illinois, and New York. As of May 17, 2010, Musculoskeletal Transplant operates as a subsidiary of California Transplant Donor Network.
125 May Street
Edison, NJ 08837
Founded in 1987
Key Executives for Musculoskeletal Transplant Foundation
Chief Executive Officer and President
Executive Vice President of Processing Operations
Executive Vice President of Research & Development
Executive Vice President of Donor Services
Compensation as of Fiscal Year 2014.
Musculoskeletal Transplant Foundation Key Developments
MiMedx Group Files Lawsuit Against Liventa, Medline, And Musculoskeletal Transplant Foundation
Apr 22 14
MiMedx Group, Inc. announced that it has filed a patent infringement lawsuit against Liventa Bioscience, Inc., Medline Industries, Inc. and Musculoskeletal Transplant Foundation, Inc. for permanent injunctive relief and unspecified damages. In addition to the allegations of infringement of MiMedx's patents, the lawsuit asserts that Liventa and Medline knowingly and willfully made false and misleading representations about their respective products to providers, patients and in some cases, prospective investors. The suit was filed in the United States District Court for the Northern District of Georgia. In the suit, MiMedx asserts that Liventa, Medline and MTF infringed and continue to infringe at least four MiMedx patents: US 8,323,701 -- Placental Tissue Grafts, US 8,642,092 -- Placental Tissue Grafts, US 8,372,437 - Placental Tissue Grafts and US 8,597,687 -- Methods for Determining the Orientation of a Placental Tissue Graft. The patents at issue relate to the MiMedx dehydrated human amnion/chorion membrane allografts. MTF is the processor and Liventa and Medline are the distributors of the allegedly infringing products.
Orthofix Holdings, Inc. and Musculoskeletal Transplant Foundation Amend Matrix Commercialization Collaboration Agreement
Jul 8 13
Orthofix International N.V. is party, through its wholly owned subsidiary, Orthofix Holdings, Inc. (Orthofix), to a Matrix Commercialization Collaboration Agreement, dated as of July 24, 2008, between Orthofix and Musculoskeletal Transplant Foundation (MTF), as amended by amendment No. 1 thereto dated December 15, 2010 and amendment No. 2 thereto dated January 9, 2012. On July 1, 2013, Orthofix and MTF entered into amendment No. 3 to Matrix Commercialization Collaboration Agreement. Under the amendment, which is effective as of June 25, 2013, Orthofix and MTF have agreed to collaborate to develop and commercialize a third generation of the stem cell-based bone growth biologic matrix currently sold and marketed as Trinity Evolution (the Matrix III). The amendment provides that MTF will develop and improve the Matrix III, and that Orthofix will provide funding support to MTF in connection with this development. In addition, Orthofix will develop application tools and instruments in connection with the Matrix III. The Amendment also provides that the parties will share responsibility for contributing scientific or medical personnel, technical expertise and other resources to the development and improvement of the Matrix III, communicating findings and discoveries to one another with respect to the Matrix III and exchanging information related to such collaboration.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|